Alex Thompson
Stock Analyst at Stifel
(3.98)
# 596
Out of 5,111 analysts
41
Total ratings
60.61%
Success rate
10.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Thompson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Maintains: Buy | $254 → $256 | $213.24 | +20.05% | 4 | Dec 11, 2025 | |
| ARGX argenx SE | Maintains: Buy | $1,028 → $1,248 | $850.95 | +46.66% | 5 | Dec 11, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $80 → $56 | $45.56 | +22.91% | 2 | Dec 11, 2025 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $52 → $65 | $41.92 | +55.06% | 2 | Sep 12, 2025 | |
| TVTX Travere Therapeutics | Maintains: Hold | $20 → $25 | $34.76 | -28.08% | 4 | Sep 12, 2025 | |
| CGEM Cullinan Therapeutics | Reinstates: Buy | $22 | $10.82 | +103.33% | 1 | Jun 11, 2025 | |
| KYMR Kymera Therapeutics | Reinstates: Buy | $55 | $85.68 | -35.81% | 1 | May 20, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $36 | $17.70 | +103.39% | 1 | Mar 25, 2025 | |
| CRNX Crinetics Pharmaceuticals | Initiates: Buy | $60 | $49.32 | +21.65% | 1 | Mar 25, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $49 | $30.10 | +62.79% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 → $54 | $33.34 | +61.97% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $2 | $8.34 | -76.02% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $14.32 | +381.84% | 2 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $2 → $1 | $3.17 | -68.45% | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $33.03 | +21.10% | 2 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $33.22 | +863.42% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $34 | $26.00 | +30.77% | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.24 | +2,561.29% | 1 | Dec 14, 2022 |
Ascendis Pharma
Dec 11, 2025
Maintains: Buy
Price Target: $254 → $256
Current: $213.24
Upside: +20.05%
argenx SE
Dec 11, 2025
Maintains: Buy
Price Target: $1,028 → $1,248
Current: $850.95
Upside: +46.66%
AnaptysBio
Dec 11, 2025
Maintains: Buy
Price Target: $80 → $56
Current: $45.56
Upside: +22.91%
Dianthus Therapeutics
Sep 12, 2025
Maintains: Buy
Price Target: $52 → $65
Current: $41.92
Upside: +55.06%
Travere Therapeutics
Sep 12, 2025
Maintains: Hold
Price Target: $20 → $25
Current: $34.76
Upside: -28.08%
Cullinan Therapeutics
Jun 11, 2025
Reinstates: Buy
Price Target: $22
Current: $10.82
Upside: +103.33%
Kymera Therapeutics
May 20, 2025
Reinstates: Buy
Price Target: $55
Current: $85.68
Upside: -35.81%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $36
Current: $17.70
Upside: +103.39%
Crinetics Pharmaceuticals
Mar 25, 2025
Initiates: Buy
Price Target: $60
Current: $49.32
Upside: +21.65%
Oruka Therapeutics
Oct 11, 2024
Initiates: Buy
Price Target: $49
Current: $30.10
Upside: +62.79%
Mar 26, 2024
Reiterates: Buy
Price Target: $36 → $54
Current: $33.34
Upside: +61.97%
Dec 18, 2023
Maintains: Hold
Price Target: $6 → $2
Current: $8.34
Upside: -76.02%
Dec 18, 2023
Maintains: Buy
Price Target: $66 → $69
Current: $14.32
Upside: +381.84%
Dec 18, 2023
Maintains: Hold
Price Target: $2 → $1
Current: $3.17
Upside: -68.45%
Sep 13, 2023
Reiterates: Buy
Price Target: $40
Current: $33.03
Upside: +21.10%
Aug 9, 2023
Initiates: Buy
Price Target: $320
Current: $33.22
Upside: +863.42%
Jul 18, 2023
Maintains: Buy
Price Target: $28 → $34
Current: $26.00
Upside: +30.77%
Dec 14, 2022
Initiates: Buy
Price Target: $33
Current: $1.24
Upside: +2,561.29%